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Abstract
Sphingosine-1-phosphate (S1P) is a key regulator of immune response. Immune cells, epithelia and blood cells generate
high levels of S1P in inflamed tissue. However, it is not known if S1P acts on the endings of nociceptive neurons, thereby
contributing to the generation of inflammatory pain. We found that the S1P1 receptor for S1P is expressed in
subpopulations of sensory neurons including nociceptors. Both S1P and agonists at the S1P1 receptor induced
hypersensitivity to noxious thermal stimulation in vitro and in vivo. S1P-induced hypersensitivity was strongly attenuated in
mice lacking TRPV1 channels. S1P and inflammation-induced hypersensitivity was significantly reduced in mice with a
conditional nociceptor-specific deletion of the S1P1 receptor. Our data show that neuronally expressed S1P1 receptors play
a significant role in regulating nociceptor function and that S1P/S1P1 signaling may be a key player in the onset of thermal
hypersensitivity and hyperalgesia associated with inflammation.
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Introduction
Thermal and mechanical hypersensitivity, and ongoing pain, are
distressing symptoms common to many inflammatory conditions. The
inflammatory process involves a multitude of cellular interactions
between local tissue components, invading cells of the immune system
and the peripheral terminals of nociceptive neurons (nociceptors).
Bioactive lipids are strongly associated with inflammation including
chronic inflammatory diseases such as relapsing multiple sclerosis (MS)
or rheumatoid arthritis (RA) [1–4]. In particular, the sphingolipid
sphingosine-1-phosphate (S1P) has turned out to be a multifaceted
immune modulator acting intracellularly as a second messenger
molecule or extracellularly in an autocrine or paracrine manner [5–7].
Extra- and intracellular levels of S1P are tightly regulated by
sphingosine kinases (SphKs) and S1P degrading enzymes [8,9].
Activation of SphK1 is the key event in elevating S1P levels [10–
12]. S1P is deactivated by S1P-phosphatases or degraded by S1P-
lyase [13–15]. Mice deficient in both SphK1 and SphK2 are not
viable, indicating an essential cellular requirement for S1P in
addition to its role in inflammation [16].
Immune cells, epithelia and neurons can generate S1P when
stimulated by chemo-attractants like tumor necrosis factor alpha
(TNFa) or nerve growth factor (NGF) [10,17]. They release S1P
via a specific transporter, the multidrug resistance-associated
protein ABCC1 [6]. Although S1P in blood plasma may reach up
to micromolar concentrations, it is largely bound to plasma [18–
20]. Systemic S1P concentrations are increased in RA patients
[21]. Moreover, high concentrations of free S1P can arise locally
at inflammation sites [6,22]. In rheumatoid synovium S1P/S1P1
receptor signaling appears to be a key regulator of the local
immune response [2,4], and increasing evidence supports a critical
role of S1P in autoimmune processes in RA [23]. In the general
population, RA is a common cause of disability with a prevalence
of 1%, and more than 95% of the patients report moderate to
severe ongoing pain [24]. Advances in the treatment of RA with
immunosuppressive therapies promise to improve the patients’
quality of life [25,26]. In a murine model of RA, the novel immune
modulator and S1P receptor ligand FYT720 inhibits arthritis [27].
These observations led us to hypothesize that S1P may not only
regulate local immune cells, synoviocytes and osteoclasts
[23,28,29], but may also act on nociceptors to cause inflammatory
pain. We discovered that S1P1 receptors were expressed by a
subpopulation of nociceptive neurons. We found evidence that
S1P induced significant hypersensitivity in vitro and in vivo.
Moreover, we generated mice lacking the S1P1 receptor in
neurons expressing the nociceptor-specific Nav1.8 promoter.
These mice were largely protected from S1P-induced hypersen-
sitivity. Based on these results, we conclude that S1P plays a
critical role in regulating nociceptor sensitivity and that this action
is largely mediated by neuronally expressed S1P1 receptors.
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S1P-induced hypersensitivity to heat stimuli and
sensitization of nociceptor responses
The latency of the withdrawal reaction in response to radiant
heat is a reliable parameter to monitor changes in sensitivity to
painful heat stimuli in rodents [30]. Heat withdrawal latencies
were determined in wt C57BL/6J mice that received intracuta-
neous injections of S1P (5 ml, 100 mM) in phosphate-buffered
saline or vehicle only. Within fifteen minutes after injection of S1P
but not vehicle, mean withdrawal latencies decreased significantly
(p,0.05; Mann-Whitney U-test; Fig. 1A). Hypersensitivity to heat
stimulation was maintained for more than two hours; after three
hours, paw withdrawal latencies were no longer significantly
different from vehicle-injected sites.
Extracellular recordings of single unit activity from unmyelin-
ated primary afferents in an isolated skin-nerve preparation
showed that S1P increased responsiveness of nociceptive neurons
to heat stimulation. When the receptive fields of polymodal
C-fibers were exposed to a conditioning stimulus of S1P (1 mM,
5 min), the average number of action potentials in response to a
standard heat stimulus was significantly augmented compared
with the control response. Furthermore, thermal thresholds for
C-fiber activation were significantly lower after S1P application
(p,0.05, n=7; Student’s paired t-test; Fig. 1B).
S1P-induced potentiation of heat and capsaicin-activated
excitatory inward currents
The isolated skin-nerve preparation excludes the possibility of
chemotactic invasion of immune cells, and the density of resident
Figure 1. S1P-induced sensitization of heat pain behavior, nociceptor neuron discharge in vitro and heat-activated ionic currents.
(A) Injection of S1P into the paw skin (5 ml of a 100 mM S1P solution in PBS) but not vehicle (n=10, n.s.) induced a significant transient drop in paw
withdrawal latencies (PWL) in response to heat stimulation from 10.1560.63 to 3.6260.24 s (n=10, *p,0.05; ANOVA). Heat sensitization fully
recovered to baseline within three hours. (B) Discharge activity of single primary nociceptive neurons in vitro significantly increased from 2.0360.39
before (black columns) to 3.2160.50 Imp/s (grey columns) after the receptive fields of the fibers were exposed to 1 mM S1P for 5 min (n=11, p,0.05;
Wilcoxon matched pairs test). (C) After conditioning stimulation with S1P, the heat-induced current of a dorsal root ganglion neuron exhibited
increased peak amplitudes and was activated at a lower temperature compared with control. (D) Temperature-current plots of four neurons
stimulated with a ramp-shaped heat stimulus with a linear rise of temperature from room temperature to 50uC before (open circles) and after
conditioning stimulation with S1P (filled circles, threshold temperature).
doi:10.1371/journal.pone.0017268.g001
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affected nociceptive neurons directly, we performed whole-cell
patch clamp measurements of heat-evoked excitatory inward
currents (Iheat) in capsaicin-sensitive neurons acutely isolated from
mouse dorsal root ganglia (DRG). S1P caused a significant dose-
dependent increase of Iheat peak amplitudes and threshold
activation temperatures of Iheat were reduced by approximately
2uC (Fig. 1C, D). The potentiation of Iheat fully recovered within
6 min suggesting relatively short-term modulation of a thermo-
sensitive ion channel by S1P.
One important thermosensitive ion channel in nociceptive
neurons is the capsaicin-activated transient receptor potential
vanilloid receptor, TRPV1 [31]. We found that S1P augmented
capsaicin-induced currents (Icaps) with a half maximal effective
concentration of 0.55 mM under controlled single cell perfusion
conditions (500 nM capsaicin; p,0.01; n=7; Wilcoxon matched
pairs test Fig. 2A, B). The maximum increase occurred at 1 mM
S1P; lower and higher concentrations were less effective. S1P-
induced heat hyperalgesia was significantly ameliorated, but not
fully abolished, in TRPV1
2/2 mice compared with wt littermates
(Fig. 2D).
S1P1 receptor mRNA and protein expressed in distinct
neuron populations
To date, five metabotropic S1P1–5 receptors for S1P have been
identified which are members of the edg (endothelial differentiation
gene) family of G-protein coupled receptors (GPCRs) [32–35]. To
elucidate which S1P receptors were relevant for the regulation of
thermal sensitivity in sensory neurons, we performed receptor
mRNA expression profile analyses in DRG explants, in acutely
Figure 2. S1P-induced hypersensitivity largely depends on TRPV1 channels. (A) Currents elicited by the TRPV1 activator capsaicin (500 nM
for 10 s, black boxes) were strongly facilitated after S1P (1 mM, 60 s, open box). (B) Average responses to repeated stimulation with 500 nM capsaicin
before and after S1P (duration 3 s, interval 120 s). Icaps significantly increased by a factor of 3.160.74 after conditioning S1P application (n=9,
p,0.01; Wilcoxon matched pairs test) and fully recovered within 4 min. (C) Dose-response relationship for S1P-induced facilitation of Icaps.A
maximum effect was observed at a S1P concentration of 1 mM with a half-effective dose ED50 of 0.55 mM. At concentrations exceeding 1 mM the
sensitizing effect of S1P became less pronounced. (D) The S1P-induced reduction in paw withdrawal latencies was significantly attenuated but not
fully abolished in TRPV1 null mutant mice (filled squares) as compared to wt littermates (open squares, n=0, *p,0.05, **p,0.01, *** p,0.001;
ANOVA).
doi:10.1371/journal.pone.0017268.g002
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cultures. Quantitative PCR showed the following rank order of
relative receptor mRNA expression for DRG explants: S1P3 .
S1P1 . S1P2 . S1P4 . S1P5 (Fig. 3A, B). These explants contain
neurons and non-neuronal cells including satellite cells, myelinat-
ing and non-myelinating Schwann cells, resident immune cells,
endothelial cells and vascular immune cells [36]. S1P receptors
have been found expressed in most of these cell types (for review
see [37]. However, in preparations enriched with acutely isolated
sensory neurons (,1% non-neuronal cells) and in 1-day-old
neuron-enriched cultures mRNAs for S1P1, S1P2 and S1P3 but
not S1P4 and S1P5 receptors were expressed. The relative
expression levels of mRNA for S1P1–3 receptors were similar in
acutely dissociated neurons and in 1-day-old cultures (Fig. 3A, B).
Together this suggests that S1P1, S1P2 and S1P3 receptor subtypes
were expressed in sensory neurons whilst S1P4 and S1P5 subtypes
were not. We conclude, therefore, that in the explant preparations,
mRNAs for S1P4 and S1P5 receptors were probably derived from
non-neuronal cells within the DRG. Most nociceptive neurons are
small to medium-sized peripherin-positive neurons [38]. They
include glial-derived neurotrophic factor (GDNF)/protein typro-
sine kinase receptor (c-RET) dependent neurons with affinity of
the isolectin B4 (I-B4+) and NGF/tyrosine kinase A (TrkA)
dependent neurons that contain the neuropeptides calcitonin-gene
related peptide (CGRP) and substance P [39]. Immunoreactivity
for S1P1 receptor was found predominantly in small peripherin-IR
neurons in DRG sections (Fig. 3C, D, E, F). In sections and
neuron cultures, S1P1 immunoreactivity predominantly occurred
in small I-B4+, Nf200-negative neurons. A smaller group of
CGRP-IR neurons also displayed immunoreactivity for S1P1
(Table 1). Based on this co-expression profile, we predicted that
the actions of S1P on nociceptor function were most likely
mediated by the S1P1 receptor.
Agonists at S1P1 receptor induced hypersensitivity
SEW2871 was developed as a selective agonist of S1P1 receptors
[40]. Intracutaneous administration of SEW2871 (5 ml, 100 mM)
induced heat hypersensitivity in vivo, and mean paw withdrawal
latencies to noxious heat stimulation dropped significantly to a
degree similar to that obtained for S1P injection (n=8, p,0.05;
ANOVA; Fig. 4A). The time course of SEW2871-induced heat
hypersensitivity was similar to that of S1P and recovered slowly
two hours after injection. In acutely isolated neurons, Icaps was
potentiated by SEW2871 with a time course and half maximal
concentration similar to those seen in response to S1P (Fig. 3B–D).
SEW2871 facilitated Icaps, and peak current amplitudes transiently
increased in a dose-dependent manner with the maximum effect
occurring at 1 mM (2.4660.50 fold, p,0.05, n=6; Wilcoxon
matched pairs test; Fig. 4D). These similarities support our
hypothesis that nociceptor sensitization predominantly occurred
through activation of the S1P1 receptor.
Conditional and specific deletion of S1P1 receptors in
sensory neurons
Mice deficient of the S1P1 receptor die 12.5 days after
conception or birth, depending on the genetic background [41].
Therefore, conditional knockout mice lacking S1P1 selectively in
nociceptive neurons of the dorsal root ganglion (DRG) were
generated using the Cre recombinase loxP strategy and condi-
tional removal of exon 2 (Fig. 5A) which encodes the entire coding
region of S1P1 [42]. This was achieved by mating homozygous
mice carrying the loxP-flanked (floxed) S1P1 (S1P1
fl/fl) [42] with a
mouse line expressing Cre recombinase under the transcriptional
control of the nociceptor-specific Nav1.8 gene (SNS-Cre) [43]. In
SNS-Cre mice, gene recombination reportedly occurs in around
90% of small diameter (#28 mm) nociceptive sensory neurons,
commences at birth and does not affect gene expression in the
spinal cord, brain or any other organs in the body [43–45].
Sequence comparisons of PCRs using primers P1 and P3 of cDNA
from S1P1
+/+, S1P1
fl/fl and SNS-S1P1
2/2 DRG confirmed that
DRG neurons from SNS-S1P1
2/2 mice lacked mRNA for S1P1
receptors. Moreover, antibodies directed against the S1P1 receptor
[46] showed immunoreactivity to S1P1 receptor protein in DRG
from S1P1
fl/fl but not SNS-S1P1
2/2 mice (Fig. 5B, C). For
quantitative analysis, we recorded capsaicin-induced calcium
transients in DRG neurons before and after conditioning
stimulation with S1P which regularly induced brief calcium
transients itself. After S1P the capsaicin responses were strongly
facilitated (Fig. 5D). The number of neurons sensitized to capsaicin
after conditioning stimulation with S1P was significantly lower in
SNS-S1P1
2/2 mice compared with S1P1
fl/fl mice (p,0.01;
Student’s unpaired t-test; Fig. 5E) but the magnitude of the
increased response in sensitized neurons was similar for both
strains (Fig. 5F).
Mice lacking S1P1 in Nav1.8 expressing nociceptors show
reduced S1P-induced hypersensitivity
SNS-S1P1
2/2 mice were viable and did not show any obvious
deficits in spontaneous behavior, motor capabilities or breeding.
Baseline mechanical and thermal thresholds of cutaneous sensory
neurons were similar to S1P1
fl/fl littermates. In S1P1
fl/fl mice,
intracutaneous injection of the S1P1 receptor agonist SEW2871
resulted in a transient and significant drop in paw withdrawal
latencies which fully recovered after two hours (Fig. 6A). In SNS-
S1P1
2/2 mice, the change in heat sensitivity was equal to vehicle
injection. Lower doses of S1P itself induced a short hypersensitivity
that was similar in S1P1
fl/fl and SNS-S1P1
2/2 mice (Fig. 6B). At
higher doses, S1P induced similar reductions in withdrawal
latencies in S1P1
fl/fl and C56BL/6J wt mice, however, the
decrease in paw withdrawal latency was significantly smaller in
SNS-S1P1
2/2 (Fig. 6C). Moreover, in SNS-S1P1
2/2 mice the
decrease of paw withdrawal latency after CFA-induced inflam-
mation was significantly reduced in comparison to S1P1
fl/fl
(5.860.6 s vs. 3.360.5 s, 6 h after CFA injection; n=8; ANOVA
repeated measures and Tukey post hoc test, genotype: F(1,79)
=24.9; p,0.001, time points: F(4,79) =39.7; p,0.001; genotype
6time points: F(4,79) =2.82; p=0.033; Fig. 6D). The degree of
inflammation (shown as ratiopaw swelling; Fig. 6E) was similar in
both groups. The degree of mechanical hypersensitivity after S1P
injection was not significantly different from controls in SNS-
S1P1
2/2 mice (9.561.1 mN before vs. 3.760.8 mN, 6 h after
CFA injection; n=7; ANOVA). Based on the evidence we found,
we propose that S1P/S1P1 receptor signaling in nociceptive
primary afferents could be relevant for inflammatory pain.
Discussion
This study revealed a significant role of S1P in increasing
nociceptor sensitivity to noxious thermal stimuli in vivo and in vitro.
Specifically, both S1P and agonists selective for S1P1 receptors
acutely sensitized peripheral nociceptive nerve terminals to
noxious heat. They also augmented heat or capsaicin-activated
inward currents in nociceptive neurons resulting in their increased
excitability. S1P-induced hypersensitivity to thermal stimulation
was strongly reduced in mice lacking either TRPV1 channels or
neuronally expressed S1P1 receptors.
Heat-activated currents in sensory neurons were activated at
lower temperatures in response to S1P and nociceptors responded
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PLoS ONE | www.plosone.org 4 February 2011 | Volume 6 | Issue 2 | e17268Figure 3. Expression of S1P1 receptors in sensory neurons. (A) S1P receptor mRNA expression was detected with reverse transcription PCR in
DRG explants. (B) Quantitative real-time PCR revealed expression of S1P1, S1P2 and S1P3 mRNA in DRG explants (total), acutely isolated neurons
(acute) and 1-day-old cultures (1 d) (n=5 experiments). In contrast, S1P4 and S1P5 mRNA levels were lower in DRG explants and absent in isolated
neurons. (C) Immunoreactivity for S1P1 was present in neurons and intraganglionic capillaries (arrowhead). S1P1-IR was colocalized with
immunoreactivity for peripherin, whereas S1P1-IR was absent in NF200-positive neurons. Scale bars =50 mm. (D) S1P1 receptor colocalized with the
small neuron marker I-B4 in the vast majority of cultured neurons but usually not with CGRP or Nf200, a marker for myelinated neurons (n=4
experiments, scale bars =20 mm). (E) Size distribution of S1P1-IR positive neurons revealed that S1P1-IR expressing cells are amongst the small
diameter neurons (n=6 experiments, 304 neurons). Only 2% of S1P1-IR+ neurons had diameters .20 mm. (F) Expression of S1P1 immunoreactivity
was absent after preabsorption of the antibodies with the corresponding peptide.
doi:10.1371/journal.pone.0017268.g003
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mechanism for transducing noxious thermal stimuli became more
efficient. Moreover, treatment with S1P increased the excitability
of sensory neurons via GPCR-dependent enhancement of TTX-
resistant sodium inward currents and inhibition of potassium
outward currents [35]. In combination, these actions of S1P on
nociceptors are consistent with a significant role in inflammatory
hyperalgesia.
Primary afferent nociceptors fall into at least two distinct
subclasses: those expressing neuropeptides, especially CGRP; and
those non-peptidergic neurons expressing binding sites for I-B4. I-
B4+ neurons require glial cell-derived neurotrophic factor (GDNF)
and its receptor GFRa for trophic support. In GFRa null mutant
mice, deficient innervation of the skin by I–B4+ neurons is
accompanied by a decreased inflammatory pain response [47]. We
found that S1P1 receptors are mainly expressed by I-B4+
nociceptors but are also present in some CGRP-positive neurons.
Functionally, S1P1 receptor-dependent thermal hypersensitivity
was partly mediated via TRPV1 receptors. Furthermore, activa-
tion of S1P1 receptors augmented the effects of TRPV1 receptor
stimulation. This is an unexpected result since, in mice, only a
small proportion of non-peptidergic I-B4+ neurons normally
expresses the TRPV1 receptor [48–50]. However, exposure to
protons massively increases the number of I-B4 neurons expressing
TRPV1 receptors [51] and capsaicin induces ATF-3 translocation
not only in peptidergic but also in I-B4+ non-peptidergic neurons
[52]. Taken together, these observations indicate that functional
TRPV1 and S1P1 receptors are probably co-expressed by subsets
of peptidergic and non-peptidergic nociceptors in mice.
When applied intrathecally, S1P and FTY720 improve pain-
related behavior in the formalin assay and modulate nociceptive
processing via inhibition of neuronal cAMP synthesis at spinal
cord level [32,53]. This analgesic effect seems to oppose the
pronociceptive effects of S1P we found at peripheral nociceptors
and somewhat resembles the situation of endocannabinoids in
nociception: depending on their site of action agonists at
cannabinoid receptor 1 (CB1) exert analgesic effects via CB1
receptors expressed at peripheral nociceptors [44] or proalgesic
effects at spinal cord level where they mediate C-fiber induced
heterosynaptic pain sensitization via CB1 receptors expressed on
spinal neurons [54]. Similar differential signaling pathways may
apply for S1P and its receptors expressed on primary afferent
nociceptors or spinal neurons.
To date it is unknown which of the S1P receptors mediate the
spinal inhibitory effect. We generated mice lacking the S1P1
receptor in Nav1.8 expressing primary afferent nociceptors. These
mice are largely resistant to S1P-induced hypersensitivity and to
inflammatory thermal hypersensitivity. Together with data using
S1P1 agonist SEW2871 we prove evidence that the proalgesic
action of S1P on nociceptive nerve terminals is largely mediated by
S1P1 receptors expressed by a subpopulation of sensory neurons.
The remaining mild hypersensitivity may be explained by either
S1P effects on non-neuronal S1P receptor expressing cells which in
turn may release proalgesic substances. Second, SNS-Cre
recombination only occurs in 90% of Nav1.8 positive neurons
[45]. The few neurons still expressing S1P1 or nociceptors
expressing other S1P receptors may also account for the remaining
S1P effects.
This study provides evidence that S1P exerts a peripheral
pronociceptive action by targeting neuronally expressed S1P1
receptors. The concept that S1P not only regulates inflammation
but simultaneously tunes pain sensitivity is intriguing and suggests
that S1P could contribute to conditions of chronic inflammatory
pain like RA. If so, the development of antagonists simultaneously
targeting S1P1 receptors in hyperreactive immune cells and
hypersensitive peripheral nociceptors would be of great clinical
benefit.
Materials and Methods
Ethic statement
All animal experiments have been performed with permission of
the Austrian BMWF ministry (BMWF-66.011/0113-II/3b/2010;
BMWF-66.011/0051-II/10b2008; GZ 66.011/85-C/GT/2007)
and according to ethical guidelines of the IASP (International
Association for the Study of Pain).
Behavioral test
MaleC57BL/6Jmice (.8 weeks old) from aninbredcolonywere
used in the experiments. TRPV1
-/- mice were a generous gift of J.B.
Davis, GSK, Harlow, UK. Mice were housed on a 12 h light/dark
cycle with free access to mouse chow and water. Standard testing
procedures were used to quantify signs of pain-like behavior
reflected by changes in thermal sensitivity. The area tested was the
plantar side of the hind paw. Compounds were injected
intracutaneously in a total volume of 5 ml. The experimenter was
unaware of the nature of the treatment. Baseline measurements
were taken twice on two days before and after injection for acute
changes in heat sensitivity up to 24 hours post injection. Mice were
placed in a plastic chamber and allowed to habituate for at least one
hour. Heat sensitivity was assessed using the Hargreaves test [30]. A
radiant heat source which delivered an increasing heat stimulus was
focused on the plantar surface of the hind paw; the time from
initiation of the radiant heat until paw withdrawal (paw withdrawal
latency) was measured automatically (Ugo Basile, Italy). Each paw
was tested three times and mean withdrawal latency was calculated.
The interval between two trials on the same paw was at least one
minute. All mice were maintained under SPF conditions.
Littermates were used in all experiments to control for background
effects and all animal use procedures were in accordance with
ethical guidelines and animal welfare standards according to
Austrian law. All behavioral measurements were done in awake,
unrestrained,age-matchedmicethatweremorethan 8weeksoldby
individuals who were blinded to the genotype of the mice being
analyzed. The swelling of the hind (frontal and sagittal diameters)
paw due to inflammation was measured after 48 h using a digital
Vernier micrometer.
Skin-nerve preparation and single fiber recordings
An in vitro skin-nerve preparation was used to investigate the
properties of cutaneous afferent nerve fibers as previously
published [55,56]. Briefly, the preparation was superfused
(15 ml/min) with modified synthetic interstitial solution containing
(in mM) 108 NaCl, 3.48 KCl, 3.5 MgSO4, 26 NaHCO3, 1.7
Table 1. Percentages of immunoreactive neurons (n=6 mice,
n=1129 neuronal profiles).
S1P1
% of total number diameter [mm]
Immunoreactive
neurons/DRG section,
35.868.1 18.660.8
Colocalization with CGRP+ 6. 862.3 17.560.9
Colocalization with Nf200+ ,1%
doi:10.1371/journal.pone.0017268.t001
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sucrose saturated with oxygen with a temperature of 3161uC and
pH 7.460.05. Action potentials of single sensory neurons were
recorded extracellularly from fine filaments dissected from the
saphenous nerve, amplified (5000 fold), filtered (low pass 1 kHz,
high pass 100 Hz), visualized on an oscilloscope and stored on a
PC-type computer with the Spike/Spidi software package [57].
The fibers were characterized as unmyelinated (C) according to
their conduction velocity and the receptive field was identified by
mechanical probing of the skin with a glass rod. Standard heat
stimuli with linear rise of the intracutaneous temperature (from
3161uCt o4 7 uC) were applied. A fiber was considered heat-
sensitive if three or more action potentials were evoked during the
stimulus. The heat threshold was either defined as the temperature
that elicited the third spike of the response or as the temperature
that evoked an instantaneous frequency of .1 imp/s. Both
measures gave identical results. In order to prevent contamination
of the entire preparation, chemical stimulation with S1P was
Figure 4. Significance of S1P1-mediated heat hypersensitivity. (A) Injection of the S1P1-selective agonist SEW2871 induced a significant
reduction of PWL in C57BL/6J mice (100 mM, 5 ml, n=8, *p,0.05, **p,0.01; ANOVA). (B) Conditioning stimulation of DRG neurons with the S1P1
agonist SEW2871 (1 mM) induced an increase in Icaps in an isolated DRG neuron. (C) SEW2871 (1 mM) significantly elevated average responses to
consecutive capsaicin stimuli (1 to 4, 3 s at 120 s intervals) by a factor of 2.4760.41 compared with control peak amplitudes (n=6, *p,0.05; Wilcoxon
matched pairs test). (D) Dose-response relationship of SEW2871 sensitization of Icaps. The ED50 was 0.56 mM and the maximum effect was observed
with 1 mM SEW2871, the same concentration that gave the highest responses for S1P.
doi:10.1371/journal.pone.0017268.g004
S1P1 Mediated Nociceptor Sensitization
PLoS ONE | www.plosone.org 7 February 2011 | Volume 6 | Issue 2 | e17268Figure 5. SNS-S1P1
2/2 mice are largely protected from S1P-induced hypersensitivity. (A) Deletion of exon 2 in nociceptive neurons with
the SNS-Cre recombination methods in SNS-Cre:S1P1
fl/fl (SNS-S1P1
2/2) mice. (B) TaqmanH-PCR analysis of DRG explants revealed an almost complete
absence of S1P1 mRNA (n=10) in SNS-S1P1
2/2 mice in comparison to control S1P1
fl/fl mice (n=9, **p,0.01; Mann-Whitney U-test). (C) S1P1 receptor
immunoreactivity is expressed in a subpopulation of small size sensory neurons in DRG sections obtained from S1P1
fl/fl but not in SNS-S1P1
2/2 mice.
There is no difference in the expression profile of CGRP immunoreactivity. (D) Example of a neuron that responded to capsaicin (arrows) with calcium
transients. S1P itself induced a brief transient which recovered immediately and the following response to capsaicin was strongly increased. (E, F) The
percentage of neurons responding to S1P with an increase in capsaicin-induced calcium transients was significantly reduced in SNS-S1P1
2/2 mice
compared to S1P1
fl/fl mice.
doi:10.1371/journal.pone.0017268.g005
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positioning a self-sealing metal cylinder around the receptive field.
DRG neuron culture
Lumbar dorsal root ganglia (DRG) with the cell bodies of
primary afferents that project into the hind paw were harvested
from adult C57BL/6J mice, treated enzymatically with collage-
nase (LiberaseH, Roche) and trypsin-EGTA (Invitrogen), and
dissociated mechanically with a fire-polished Pasteur pipette as
previously published [58,59]. The resulting cell suspension was
washed, plated on glass coverslips coated with poly-L-lysine/
laminin (Sigma) and cultivated in synthetic serum-free medium
(supplemented TNB
TM, Biochrom, Vienna) at 37uCi n5 %C O 2.
Patch-clamp recordings
Using the whole-cell voltage-clamp configuration of the patch-
clamp technique, ionic currents were recorded from isolated
neurons at 280 mV holding potential after 18–32 hours as
previously published [58,59]. The external solution (ECS)
contained (in mM): 145 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2 (all
Sigma), 10 glucose and 10 HEPES (Merck, Darmstadt, Germany),
at pH 7.3 adjusted with NaOH (Merck). Borosilicate glass
micropipettes (Science Products, Hofheim, Germany) pulled with
a horizontal puller (Sutter Instruments Company, Novato, CA,
USA) were filled with internal solution (ICS, in mM): 148 KCl, 2
MgCl2, 2 Na-ATP, 0.2 Na-GTP, 0.1 CaCl2, 1 EGTA (all Sigma)
and 10 HEPES (Merck), at pH 7.3 adjusted with KOH (Merck).
Figure 6. Reduced thermal hypersensitivity in S1P1
2/2mice. (A) Injection of the S1P1 agonist SEW2871 induced a significant transient
decrease in paw withdrawal latencies in S1P1
fl/fl (n=9) which was significantly less pronounced than in SNS-S1P1
2/2 mice (n=10, *p,0.05; ANOVA).
(B, C) While only a minor reduction of paw withdrawal latencies was observed in both mouse strains with local low dose S1P injection, we observed a
significant decrease in paw withdrawal latencies in S1P1
fl/fl mice (n=7) which was similar to wt. In SNS-S1P1
2/2 mice the degree of hypersensitivity
was significantly ameliorated in comparison to S1P1
fl/fl mice (n=9, *p,0.05, ** p,0.01; ANOVA). (D) CFA (20 ml) injection into the plantar hindpaw
induced a pronounced decrease of PWL which was significantly attenuated in S1P1-Cre mice (p,0.05, n=4; ANOVA). (E) Paw swelling was similar in
SNS-S1P1
2/2 and S1P1
fl/fl mice (n=4).
doi:10.1371/journal.pone.0017268.g006
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filtered at 2.9 kHz, sampled at 3 kHz and recorded using an EPC-
9 (HEKA, Germany) and the Pulse v8.74 software (HEKA).
Experiments were performed at room temperature and only one
neuron was tested per Petri dish. An automated seven-barrel
system with common outlet at 100 mM distance to the cell under
investigation was used for fast drug administration and heat
stimulation [60]. Heat-activated inward currents (Iheat) were
elicited by applying ramp-shaped heat stimuli at 60 s intervals
(linear temperature increase from 25 to 50uC within 5 s). S1P (0.1
to 10 mM, Sigma) or SEW2871 (0.01 to 10 mM, Sigma) were used
as intermittent conditioning stimuli (60 s) followed by a 3-minute
washout. Capsaicin was purchased from Sigma Aldrich.
Tissue preparation
Specimens for RT-PCR and immunohistochemistry were
obtained from 6 to 10-week-old C57BL/6J mice of either sex.
DRG were snap-frozen in melting isopentane and stored at
280uC until required for immune staining/ISH or snap-frozen in
liquid nitrogen for RT-PCR. For analysis of cultured neurons,
50 ml aliquots containing acutely dissociated cells (n=6 mice) were
used for subsequent qRT-PCR analysis. After plating on glass-
bottom Petri dishes coated with poly-L-lysine (200 ng/ml, Sigma)
cultures were kept at 37uC in a humid atmosphere containing 5%
CO2 for 24 h. Cells grown on individual coverslips (n=6 mice)
were lysed and used for subsequent qRT-PCR analysis.
Quantitative real-time PCR
Quantitative real-time PCR (RT-qPCR) was used to quantify
levels of mRNAs using cDNA from thoracolumbar DRG, acutely
dissociated and cultured DRG neurons (Corbett Roto-cycler,
Sydney, Australia). DRG were lysed in RLTH buffer using a tissue
lyser (Qiagen Doncaster, Australia), RNA was extracted (RNeasy
Mini-kit, Qiagen) and the quantity and quality of the RNA
determined (Nanodrop, Thermo Scientific, USA, Bioanalyzer,
Agilent, USA). Acutely dissociated and primary cultures of DRG
werelysed onthecoverslip(RLTH buffer,Qiagen)and subsequently
used for RNA extraction according to the manufacturer’s
instructions (RNeasy Micro-kit, Qiagen). The extraction was
followed by DNase digestion and reverse transcription (Sensiscript,
Qiagen). The cDNA was used for subsequent qPCR. All PCR
reactions were prepared in triplicate from DRG of four to six
animals using a ready-to-use kit according to the manufacturer’s
protocol (iQ SYBR green Supermix, Bio-Rad). Primers specific for
mRNA sequences were designed using http://www.ncbi.nlm.nih.
gov/tools/primer-blast/index.cgi?LINK_LOC=BlastHomeAd.
Primers specific for the reference gene, mouse HPRT, were
used for standardization (Table 2). The efficiency of each primer
pair was determined (between 0.96 and 1.1). Data were
normalized by subtracting the threshold cycle (CT) levels between
the genes of interest and HPRT [61]. The DCT values were
subtracted from 50 showing higher values with higher expression.
Amplicons were identified by sequencing (SA Pathology and
Flinders Sequencing Facility).
Immunohistochemistry
DRG were serially cryosectioned at a thickness of 12 mm, fixed
in Zamboni’s fixative and subsequently preincubated for 1 h with
PBS containing 10% normal donkey serum, 0.1% BSA, and 0.5%
Tween 20. Indirect immunofluorescence was performed by
overnight incubation with mixtures of the primary antisera
(Table 3) at room temperature followed by washing in PBS and
subsequent incubation with appropriate combinations of second-
ary reagents (Table 3) for 1 h at room temperature. The antiserum
specifically recognizing S1P1 receptors [46] was a generous gift of
S. Mandala, Immunology, Merck Research Laboratories, Rah-
way, New Jersey, USA. Preabsorption controls using the
corresponding peptide (0.1 mg/l peptide) abolished immunolabel-
ing (Fig. 3F). After incubation with the secondary reagents, the
slides were washed in PBS and coverslipped in carbonate-buffered
glycerol at pH 8.6. The slides were evaluated by sequential
scanning using a confocal laser scanning microscope (TCS SP5,
Leica, Bensheim, Germany). For quantification studies, two
random 640 magnification, non-overlapping confocal images
from two sections from L2-L5 DRG (n=5 animals) were taken.
The longest and shortest diameter of neuronal profiles with a
clearly visible nucleus were determined and the average diameter
calculated. To assess double labeling, the neurons with clearly
visible nuclei displaying a clear fluorescent signal were counted as
immunoreactive.
Table 2. Primer pairs used.
Name GI no. Forward primer (59-39) length (bp)
Reverse primer (59-39)
hypoxanthine guanine phosphoribosyl
transferase (HPRT)
53237103 GCCCCAAAATGGTTAAGGTT 208
TTGCGCTCATCTTAGGCTTT
S1P1 = Edg1 NM_007901.3 CTCTGCTCCTGCTTTCCATC 173
GCAGGCAATGAAGACACTCA
S1P2 = Edg5 NM_010333.2 TCTCAGGGCATGTCACTCTG 162
CAGCTTTTGTCACTGCCGTA
S1P3 = Edg3 NM_010101.2 GTGTGTTCATTGCCTGTTGG 208
TTGACTAGACAGCCGCACAC
S1P4 = Edg6 NM_010102.1 GGCTACTGGCAGCTATCCTG 213
GGAGGACGTGGAGACTTCTG
S1P5 = Edg8 NM_053190.1 GATCCCTTCCTGGGTCTAGC 222
TAGAGCTGCGATCCAAGGTT
doi:10.1371/journal.pone.0017268.t002
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Mice homozygous for the floxed exon 2 allele of the mouse S1P1
receptor gene (S1P1
fl/fl), which encodes for the entire receptor protein,
have been described previously [42] and were a generous gift of R.
Proia. S1P1
fl/fl mice were cross bred with SNS-Cre mice [43] to obtain
homozygous SNS-Cre:S1P1
fl/fl (hereinafter referred to as SNS-S1P1
2/2)
and S1P1
fl/fl mice (control littermates; the recombinase is homo- or
heterozygous). For detecting the wild type, knock-out and conditional
alleles the following primers were used: 59-GAGCGGAGGAAGT-
TAAAAGTG-39,5 9-CCTCCTAAGAGATTGCAGCAA-39 and 59-
GATCCTAAGGCAATGTCCTAGAATGGGACA-39,al lf o rS 1 P 1,
and primers 59-GAAAGCAGCCATGTCCAATTTACTGACCG-
TAC-39 and 59-GCGCGCCTGAAGATATAGAAGA-39 to detect
SNS-Cre transgene expression. SNS-Cre mice, SNS-S1P1
-/- mice and
their corresponding littermates (wild-type and S1P1
fl/fl mice) had the
genetic background C57BL/6J. For genotyping with quantitative real-
time PCR, total RNA was isolated from DRG neurons immediately
after preparation using TRI Reagent
TM (Sigma) according to the
manufacturer’s instructions. Quality and degradation of RNA were
controlled by denaturating agarose gel electrophoresis. RNA was
treated with DNase I (Fermentas GmbH, St. Leon-Rot, Germany).
Reverse transcription to cDNA was carried out using the GeneAmp
RNA PCR Kit (Applied Biosystems). Each cDNA sample (100 ng) was
analyzed for expression of S1P1 by quantitative real-time PCR
using the TaqMan 59 nuclease assays Mm00514644_m1 and
Mm01352363_m1 (Succinate Dehydrogenase Subunit A, SDHA).
Reactions were performed in a MicroAmp
TM Fast Optical 96-Well
Reaction Plate (Applied Biosystems) using the 7500 Fast Real-Time
PCR System (Applied Biosystems) for thermal cycling and real-time
fluorescence measurements. The PCR cycle protocol consists of
10 min at 95uC, and 40 two-step cycles of 15 sec each at 95uCa n do f
1m i na t6 0 uC. Positive and negative controls were included in all
experiments and each sample was run in triplicate for each PCR.
Threshold cycle (CT) values were recorded as a measure of initial
template concentration. Relative fold changes in RNA levels were
calculated by the DDCT method using SDHA as a reference standard
[62]. The range for the target, relative to a calibrator sample was
calculated by 2
-DDCT.
Microfluorimetric calcium measurements
Cells were plated on glass-bottom dishes coated with poly-L-lysine
hydrobromide [10 mg/ml] and laminin [10 mg/ml] (both Sigma).
Cultured cells were loaded with fura-2/AM (3 mM in ECS) and
incubated for 30 min at 37uCi n5 %C O 2, washed twice with PBS
(PAA) and used for experiments after an extra incubation of 30 min.
Experiments were performed using an Axiovert microscope (Zeiss,
Stuttgart, Germany) with a 40x/1,3 oil objective (Zeiss). Fura-2 was
excited with a Xe-lamp at 340 nm and 380 nm (exposure time: 50 ms)
with a polychrome IV monochromator (TILL Photonics GmbH,
Munich, Germany), fluorescence intensity changes were recorded with
a CCD camera (TILL Photonics) at 510 nm to determine fluorescence
intensity ratios at this wavelength as previously published [63]. For data
acquisition MetaFluor4.6r8 (Universal Imaging Corp., Franklin, USA)
was used and off-line analysis was performed with OriginPro7.SR2
(Origin Lab Corporation).
Statistical analysis
For detailed statistical analysis the SigmaStat 3 software package
was used. Data are presented as mean 6 s.e.m. Statistical tests
were used depending on sample size, distribution and number of
variables: One- or two-way ANOVA followed by post hoc test, the
non-parametric Mann-Whitney U-test or the parametric Student’s
unpaired t-test for comparison between groups; for intra-
individual comparisons, the Wilcoxon matched pairs test or the
parametric Student’s paired t-test was used. Differences were
considered statistically significant at p,0.05.
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